Cite
Evaluation and refinement of the PRESTARt tool for identifying 12–14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study.
MLA
Gray, Laura J., et al. “Evaluation and Refinement of the PRESTARt Tool for Identifying 12–14 Year Olds at High Lifetime Risk of Developing Type 2 Diabetes Compared to a Clinicians Assessment of Risk: A Cross-Sectional Study.” BMC Endocrine Disorders, vol. 19, no. 1, July 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s12902-019-0410-3.
APA
Gray, L. J., Brady, E. M., Albaina, O., Edwardson, C. L., Harrington, D., Khunti, K., Miksza, J., Raposo, J. F., Smith, E., Vazeou, A., Vergara, I., Weihrauch-Blüher, S., & Davies, M. J. (2019). Evaluation and refinement of the PRESTARt tool for identifying 12–14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study. BMC Endocrine Disorders, 19(1), N.PAG. https://doi.org/10.1186/s12902-019-0410-3
Chicago
Gray, Laura J., Emer M. Brady, Olatz Albaina, Charlotte L. Edwardson, Deirdre Harrington, Kamlesh Khunti, Joanne Miksza, et al. 2019. “Evaluation and Refinement of the PRESTARt Tool for Identifying 12–14 Year Olds at High Lifetime Risk of Developing Type 2 Diabetes Compared to a Clinicians Assessment of Risk: A Cross-Sectional Study.” BMC Endocrine Disorders 19 (1): N.PAG. doi:10.1186/s12902-019-0410-3.